| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2938 | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1516 | 2020 |
| Empagliflozin in patients with chronic kidney disease EMPA-Kidney Collaborative Group New England Journal of Medicine 388 (2), 117-127, 2023 | 1291 | 2023 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1219 | 2021 |
| Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus ASCEND Study Collaborative Group New England Journal of Medicine, 2018 | 1211 | 2018 |
| Effects of anacetrapib in patients with atherosclerotic vascular disease HPS3/TIMI55–REVEAL Collaborative Group New England Journal of Medicine 377 (13), 1217-1227, 2017 | 965 | 2017 |
| Effects of n− 3 Fatty Acid Supplements in Diabetes Mellitus ASCEND Study Collaborative Group New England Journal of Medicine, 2018 | 772 | 2018 |
| Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. S Lewis, JR Geddes, G Goodwin, R Morriss, J Rendell, MJ Attenburrow, ... Lancet 375 (9712), 385-95, 2010 | 599 | 2010 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10289), 2049, 2021 | 330 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10325), 665, 2022 | 224 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 222 | 2021 |
| The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study JM Bopp, DJ Miklowitz, GM Goodwin, W Stevens, JM Rendell, JR Geddes Bipolar disorders 12 (3), 327-334, 2010 | 215 | 2010 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 208 | 2022 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 153 | 2021 |
| ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes JA Louise Bowman,Marion Mafham,William Stevens,Richard Haynes,Theingi Aung ... American Heart Journal, 2017 | 127* | 2017 |
| Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial Nephrology Dialysis Transplantation 37 (7), 1317-1329, 2022 | 100 | 2022 |
| Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of … MJ Landray, L Bowman, F Chen, E Sammons, JC Hopewell, ... American heart journal 187, 182-190, 2017 | 66 | 2017 |
| The True Colours Remote Symptom Monitoring System: A Decade of Evolution SM Goodday, L Atkinson, G Goodwin, K Saunders, M South, C Mackay, ... Journal of Medical Internet Research 22 (1), e15188, 2020 | 46 | 2020 |
| Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease E Sammons, JC Hopewell, F Chen, W Stevens, K Wallendszus, ... European heart journal, 2021 | 41 | 2021 |
| Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial S Parish, M Mafham, A Offer, J Barton, K Wallendszus, W Stevens, G Buck, ... European Heart Journal 43 (21), 2010-2019, 2022 | 35 | 2022 |
